Topical corticosteroids versus topical inhibitors of calcineurin;Topische kortikoide versus calcineurinantagonisten

Hautarzt

Volumn 54, Issue 4, 2003, Pages 338-341

  Niedner, R ^a  

^a KLINIKUM ERNST VON BERGMANN   (Germany)

Author keywords

Pimecrolimus; Tacrolimus; Topical glucocorticoids; Topical inhibitors of calcineurin

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; CYTOKINE; GLUCOCORTICOID; NITRIC OXIDE SYNTHASE; PIMECROLIMUS; TACROLIMUS; ANTIINFLAMMATORY AGENT; CALCINEURIN; CYCLOSPORIN DERIVATIVE; IMMUNOSUPPRESSIVE AGENT;

ANTIINFLAMMATORY ACTIVITY; DRUG COST; DRUG EFFICACY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; REVIEW; RISK BENEFIT ANALYSIS; ACUTE DISEASE; ATOPIC DERMATITIS; COMPARATIVE STUDY; DRUG ANTAGONISM; ECZEMA; NEURODERMATITIS; PSORIASIS; PYODERMA GANGRENOSUM; RISK FACTOR; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION;

ACUTE DISEASE; ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; CALCINEURIN; CYCLOSPORINS; DERMATITIS, ATOPIC; ECZEMA; FACIAL DERMATOSES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NEURODERMATITIS; PSORIASIS; PYODERMA GANGRENOSUM; RISK FACTORS; SKIN DISEASES; TACROLIMUS;

EID: 0038003698     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-003-0488-3     Document Type: Review

References (21)

1. Bornhovd EC, Schuller E, Bieber T, Wollenberg A (2000) Immunsuppressive Makrolide und ihr Einsatz in der Dermatologie. Hautarzt 51:646-654
2. Cornell RC, Maibach HI (1992) Clinical indications: real and assumed. In: Maibach HI, Surber C (eds) Topical corticosteroids. Karger, Basel, pp 154-162
3. Dissemond J, Goos M, Wagner SN (2002) Pimecrolimus (SDZ ASM 981). Aktueller Stand der Forschung. Dtsch Med Wochenschr 127:1199-1203
4. Eichenfield LF, Lucky AW, Boguniewicz M et al. (2002) Safety and efficacy of pimecrolimus (ASM 98 J) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adotescents. J Am Acad Dermatol (United States) 46:49S-504
5. Goldman D (2001) Tacrolimus ointment for the treatment of steroid-inctuced rosacea: a preliminary report. J Am Acad Dermatol (United States) 44:995-998
6. Griffiths CE (2001) Ascomycin: an advance in the management of atopic dermatitis. Br J Dermatol (England) 144:679-681
7. Kaliakatsou F, Hodgson TA, Lewsey JD et al. (2002) Management of recalcitrant ulcerative oral lichen planus with topical tacrolymus. J Am Acad Dermatol (United States) 46:35-41
8. Luger T, Van Leent EJ, Graeber M et al. (2001) SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis. Br J Dermatol (England) 144:788-794
9. Mrowietz U, Graeber M, Brautigam M et al. (1998) The novel ascomycin derivative SDZ ASM 981 is effective for psorasis when used topically under occlusion. Br J Dermatol 139:992-996
10. Nghiem P, Pearson G, Langley RG (2002) Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol (United States) 46:228-241
11. Reitamo S, Rustin M, Ruzicka T (2002) Efficacy and safety of tacrolimus ointment compared with hydrocortisone butyrate ointment in adult patients with atopic dermatitis. The European Tacrolimus Ointment Study Group. J Allergy Clin Immunol 109:547-555
12. Remitz A, Reitamo S, Erkko P et al. (1999) Tacrolimus ointment improves psoriasis in a microplaque assay. Br J Dermatol (England) 141:103-107
13. Rozycki TW, Rogers RS, Pittelkow MR et al. (2002) Topical tacrolimus in the treatment of symptomatic oral lichen planus: a series of 13 patients. J Am Acad Dermatol (United States) 46:27-34
14. Schnopp C, Remling R, Mohrenschlager M et al. (2002) Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial. J Am Acad Dermatol (United States) 46:73-77
15. Schöpf E (1972) Nebenwirkungen externer Corticosteroidtherapie. Hautarzt 23:294-299
16. Suga Y, Tsuboi R, Hashimoto Y et al. (2000) A case of ichthyosis linearis circumflexa successfully treated with topical tacrolimus, J Am Acad Dermatol (United States) 42:520-522
17. Suga Y, Hashimoto Y, Matsuba S et al. (2002) Topical tacrolimus for chronic actinic dermatitis. J Am Acad Dermatol (United States) 46:321-323
18. Vente C, Reich K, Rupprecht R, Neumann C (1999) Erosive mucosal lichen planus: response to topical treatment with tacrolimus. Br J Dermatol (England) 140:338-342
19. Weichert G, Sauder DN (2000) Efficacy of tacrolimus (FK 506) in idiopathic treatment-resistant pyoderma gangraenosum J Am Acad Dermatol. 42:304-305
20. Wellington K, Jarvis B (2002) Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis. Drugs (New Zealand) 62:817-840
21. Zabawski EJ, Costner M, Cohen JB, Cockerell CJ (2000) Tacrolimus: pharmacologv and therapeutic uses in dermatology. Int J Dermatol (United States) 39:721-727